The biggest risk is not product viability but paying a premium price today for execution that still depends on regulatory clearance, disciplined deal financing, clean integration and durable supply. If AI timing demand normalizes, or if larger vendors bundle timing more effectively, the stock can
rerate before revenue fully catches up.